M.D.C. (MDC)
(Delayed Data from NYSE)
$40.33 USD
-0.83 (-2.02%)
Updated Feb 3, 2023 04:00 PM ET
After-Market: $40.31 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Income Statements
Fiscal Year end for MDC Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | NA | 5,255 | 3,901 | 3,293 | 3,065 |
Cost Of Goods | NA | 3,926 | 3,035 | 2,646 | 2,475 |
Gross Profit | NA | 1,329 | 866 | 647 | 590 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 494 | 403 | 363 | 335 |
Income After Depreciation & Amortization | 0 | 835 | 463 | 284 | 255 |
Non-Operating Income | NA | -83 | -5 | 21 | 9 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 752 | 458 | 305 | 264 |
Income Taxes | NA | 178 | 90 | 67 | 53 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 574 | 368 | 238 | 211 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 574 | 368 | 238 | 211 |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 867 | 490 | 307 | 276 |
Depreciation & Amortization (Cash Flow) | NA | 32 | 27 | 23 | 21 |
Income After Depreciation & Amortization | 0 | 835 | 463 | 284 | 255 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | NA | 72.86 | 70.68 | 68.80 | 66.78 |
Diluted EPS Before Non-Recurring Items | NA | 7.83 | 5.17 | 3.44 | 3.40 |
Diluted Net EPS (GAAP) | NA | 7.83 | 5.17 | 3.44 | 3.14 |
Fiscal Year end for MDC Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 | |
---|---|---|---|---|---|
Sales | NA | 1,441.74 | 1,487.05 | 1,269.65 | 1,465.89 |
Cost Of Goods | NA | 1,088.41 | 1,062.02 | 922.04 | 1,082.11 |
Gross Profit | NA | 353.33 | 425.04 | 347.61 | 383.78 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 141.44 | 133.85 | 129.31 | 130.02 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 211.89 | 291.19 | 218.30 | 253.76 |
Non-Operating Income | NA | -26.11 | -32.22 | -16.42 | -44.61 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 185.79 | 258.96 | 201.88 | 209.15 |
Income Taxes | NA | 41.39 | 69.42 | 53.46 | 46.49 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 144.40 | 189.54 | 148.42 | 162.66 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 144.40 | 189.54 | 148.42 | 162.66 |
Earnings Per Share Data | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 |
---|---|---|---|---|---|
Average Shares | NA | 72.73 | 72.88 | 72.94 | 73.11 |
Diluted EPS Before Non-Recurring Items | NA | 1.98 | 2.59 | 2.02 | 2.21 |
Diluted Net EPS (GAAP) | NA | 1.98 | 2.59 | 2.02 | 2.22 |